| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |